Section 128a

EU compulsory licences
Previous Index Next

(1) In this Act an "EU compulsory licence" means a compulsory licence granted under Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems(4) (referred to in this Act as "the Compulsory Licensing Regulation").

(2) In the application to EU compulsory licences of the provisions of this Act listed in subsection (3) -

  • (a) references to a licence under a patent,
  • (b) references to a right under a patent, and
  • (c) references to a proprietary interest under a patent,

include an EU compulsory licence.

(3) The provisions referred to in subsection (2) are -

  • sections 32 and 33 (registration of patents etc);
  • section 37 (determination of right to patent after grant);
  • section 38 (effect of transfer etc of patent under section 37), apart from subsection (2) and subsections (3) to (5) so far as relating to subsection (2);
  • section 41 (amount of compensation);
  • section 46(2) (notice of application for entry that licences are available as of right);
  • section 57(1) and (2) (rights of third parties in respect of Crown use).

(4) In the following provisions references to this Act include the Compulsory Licensing Regulation -

(5) In section 108 (licences granted by order of comptroller) the reference to a licence under section 11, 38, 48 or 49 includes an EU compulsory licence.

(6) References in this Act to the Compulsory Licensing Regulation are to that Regulation as amended from time to time.

Notes
Manual of Patent Practice
Sections 128A & 128B, together with Schedule 4A, were introduced by SI 2007 No. 3293, in force as from 17 December 2007.

Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License